These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8561139)

  • 1. Stalking the guardian of the genome: p53 in colorectal carcinogenesis.
    Ahnen DJ
    Am J Gastroenterol; 1996 Jan; 91(1):3-6. PubMed ID: 8561139
    [No Abstract]   [Full Text] [Related]  

  • 2. p53 mutations in primary colorectal adenocarcinomas and liver metastases.
    Yao J; Goh HS; Smith DR
    Br J Surg; 1996 Sep; 83(9):1245-6. PubMed ID: 8983617
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of mutation and conformation on the function of p53 in colorectal cancer.
    Webley KM; Shorthouse AJ; Royds JA
    J Pathol; 2000 Aug; 191(4):361-7. PubMed ID: 10918210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
    Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
    J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of the K-ras and p53 genes and microsatellite instability in sporadic colorectal carcinomas.
    Hasegawa A; Fukushima T; Mashiko M; Nakano K; Suzuki S; Endo Y; Ohki S; Hatakeyama Y; Koyama Y; Inoue N; Takebayashi Y; Sekikawa K; Takenoshita S
    Anticancer Res; 2004; 24(3b):2047-52. PubMed ID: 15274399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staining patterns of p53 immunohistochemistry and their biological significance in colorectal cancer.
    Kaserer K; Schmaus J; Bethge U; Migschitz B; Fasching S; Walch A; Herbst F; Teleky B; Wrba F
    J Pathol; 2000 Mar; 190(4):450-6. PubMed ID: 10699994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analysis of the expression of p53 gene in colorectal carcinoma by using real-time PCR.
    Bong I; Lim P; Balraj P; Sim Ui Hang E; Zakaria Z
    Trop Biomed; 2006 Jun; 23(1):53-9. PubMed ID: 17041552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Colorectal cancers].
    Miyoshi Y; Nakamura Y
    Tanpakushitsu Kakusan Koso; 1997 Jul; 42(10 Suppl):1723-31. PubMed ID: 9279105
    [No Abstract]   [Full Text] [Related]  

  • 9. [The expression of mutation p53 gene from circulating cancer cells of peripheral blood and the clinical significance in detecting the patients with colorectal cancer].
    Ma GJ; Zhou JN; Shen ZL; Chen SQ; Zhu YQ; Wu XL; Xue KX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Apr; 23(2):186-8. PubMed ID: 16604493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. K-ras and p53 gene mutations in colorectal cancer in 57 Japanese patients.
    Onda M; Abe R; Tsuchiya A; Fukushima T; Ando Y; Yoshida T
    Fukushima J Med Sci; 1997 Jun; 43(1):29-39. PubMed ID: 9431782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of analysis of p53 alteration and observation of surface microstructure for diagnosis of ulcerative colitis-associated colorectal neoplasia.
    Fujii S; Fujimori T; Chiba T
    J Exp Clin Cancer Res; 2003 Mar; 22(1):107-15. PubMed ID: 12725330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P53 mutations in colorectal cancer assessed in both genomic DNA and cDNA as compared to the presence of p53 LOH.
    Forslund A; Kressner U; Lönnroth C; Andersson M; Lindmark G; Lundholm K
    Int J Oncol; 2002 Aug; 21(2):409-15. PubMed ID: 12118339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High incidence of protein-truncating mutations of the p53 gene in liver metastases of colorectal carcinomas.
    Miyaki M; Iijima T; Yasuno M; Kita Y; Hishima T; Kuroki T; Mori T
    Oncogene; 2002 Sep; 21(43):6689-93. PubMed ID: 12242668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The tumor suppressor p53: "guardian of our genomes"].
    Deppert W
    Med Monatsschr Pharm; 1999 Jun; 22(6):166-73. PubMed ID: 10394793
    [No Abstract]   [Full Text] [Related]  

  • 15. Familial and nutritional risk factors for p53 overexpression in colorectal cancer.
    Freedman AN; Michalek AM; Marshall JR; Mettlin CJ; Petrelli NJ; Black JD; Zhang ZF; Satchidanand S; Asirwatham JE
    Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):285-91. PubMed ID: 8722220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic pathways of 'de novo' colorectal carcinomas with reference to fetal-type glycogen phosphorylase positive foci.
    Shiomori K; Shimada S; Marutsuka T; Hatayama I; Ogawa M
    Int J Oncol; 2003 Jan; 22(1):65-74. PubMed ID: 12469186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Have p53 gene mutations and protein expression a different biological significance in colorectal cancer?
    Bazan V; Migliavacca M; Tubiolo C; Macaluso M; Zanna I; Corsale S; Amato A; Calò V; Dardanoni G; Morello V; La Farina M; Albanese I; Tomasino RM; Gebbia N; Russo A
    J Cell Physiol; 2002 May; 191(2):237-46. PubMed ID: 12064467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of genetic changes in progression of colorectal cancer].
    Kuroda K; Watatani M; Yoshida T; Ieda S; Shindo K; Yasutomi M
    Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():164-8. PubMed ID: 8678562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inverse correlation between RER+ status and p53 mutation in colorectal cancer cell lines.
    Cottu PH; Muzeau F; Estreicher A; Fléjou JF; Iggo R; Thomas G; Hamelin R
    Oncogene; 1996 Dec; 13(12):2727-30. PubMed ID: 9000147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.